Drug
Zydpla1
Zydpla1: highest development phase Phase 1, developed by Zydus. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Zydus
Trials
| Drug | Phase | Indication |
|---|---|---|
| ZYDPLA1 tablet NCT02620592 | Phase 1 | Diabetes Mellitus |
Latest
No recent events.
Follow Zydpla1 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.